HealthTree Podcast for Multiple Myeloma

HealthTree Podcast for MM

HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Ask questions and learn about the latest innovation in simple terms patients can understand.

  1. FEB 24

    Myths vs. Facts about Diet in Multiple Myeloma

    Listen to this episode where Dr. Urvi Shah will talk about the myths and facts about food and how our diet impacts our outcomes when it comes to our myeloma journey

    1h 10m

  2. JAN 23

    The 2026 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

    The year 2026 brings new promise in multiple myeloma with a wide variety of treatment options available for both newly diagnosed and relapsed/refractory patients. Learn about the progress being made and the very latest in determining risk at diagnosis, strategies for smoldering myeloma patients, optimal treatments for newly diagnosed patients, things to consider at first relapse and beyond. Dr. Robert Orlowski will review advances in CAR T therapies, bispecific antibodies, targeted therapies, combination approaches and clinical trials to watch as the research continues advancing at a rapid pace in myeloma.

    1h 14m

  3. 09/02/2025

    2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

    The world of immunotherapy in multiple myeloma is exploding - with new treatments being FDA-approved and others working their way through the FDA approval process. In this show, Dr. Paul Richardson focuses on the innovation in immunotherapy that we've seen in the first half of 2025. This includes a discussion about CAR T, bispecific and trispecific antibodies, and a deeper dive on a new class of drugs in myeloma called Antibody Drug Conjugates, with a drug called belantamab mafodotin going through the FDA review process, with a hopeful approval in October of this year.

    30 min

  4. 09/02/2025

    2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

    Multiple myeloma treatment is advancing in promising ways. Learn about mid-year updates in multiple myeloma from the ASCO and EHA conferences and what to expect from the upcoming International Myeloma Society (IMS) meeting with Paul Richardson, MD, Dana Farber Cancer Institute.

    30 min

  5. 04/04/2025

    Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

    Learn more about Minimal Residual Disease (MRD) testing and how it’s being used today in research and for your myeloma care. Join Rafael Fonseca, MD, Mayo Clinic to learn when MRD testing should be done and how the results should be used in myeloma care

    1 hr

  6. 03/03/2025

    Preventing Myeloma Progression with Diet: The Nutrivention-2 Stu

    Through her extensive (and continuing) research, Dr. Urvi Shah, a multiple myeloma specialist at Memorial Sloan Kettering Cancer Center, is determined to find answers to the often-asked question by patients with precursor myeloma conditions, “What diet is best for me?” l Can a plant based diet affect your overall health? Can it affect your blood cancer progression or time to relapse? What does the science say about it, and what questions still need to be answered? Join us to discuss these topics and answer these questions and more.  HealthTree is working with Dr. Urvi Shah's team at MSK in "Nutrivention-2", a national, multi-arm, randomized prospective telehealth study for MGUS and smoldering myeloma patients. This study will explore the microbial changes in response to a plant-based diet and supplements in smoldering myeloma patients. You can learn more about it HERE. If you're interested and want more information, please contact our support team - support@healthtree.org.

    48 min

  7. 02/12/2025

    The Future of Bispecific Antibodies with Dr. Philippe Moreau

    Bispecific antibodies are a growing class of treatment in multiple myeloma. Learn from global expert and International Myeloma Society (IMS) President Dr. Philippe Moreau about the advances being made in bispecific antibodies and what clinicians are learning about how and when to best use this therapy. Dr. Moreau will provide a review of approved and in-development bispecific antibodies, side effect management and more. Learn how HealthTree and IMS are partnering on the HealthTree Bispecific Antibody Study to provide more data and patient experiences to help the research community come to faster conclusions about this new, exciting treatment.

    57 min

  8. 02/01/2025

    A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

    Learn about what's here and what's coming in 2025 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

    58 min
See All (180)

4.9
out of 5
19 Ratings

About

HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Ask questions and learn about the latest innovation in simple terms patients can understand.

Information

You Might Also Like